Denali Therapeutics set to advance groundbreaking treatments for neurological diseases
Biotech innovator Denali Therapeutics opened a new manufacturing hub as it develops new therapies for conditions like Hunter ...
How another firm's FDA approval could mean a big win for Denali Therapeutics
Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...
BioSpace1d
Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, ...
American Century Companies Inc. Buys 29,155 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
American Century Companies Inc. raised its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 6.5% during ...
Denali initiates BLA filing for accelerated approval of tividenofusp alfa
Denali Therapeutics (DNLI) announced that the company’s initiation of a rolling submission of a biologics license application, BLA, for ...
What Happened To Denali Therapeutics Stock Wednesday?
Denali Therapeutics, Inc. (NASDAQ:DNLI) shares traded higher on Wednesday after the company initiated its biologics license application (BLA) for the accelerated approval of Tividenofusp Alfa for the ...
William Blair Sticks to Their Buy Rating for Denali Therapeutics (DNLI)
William Blair analyst Sarah Schram maintained a Buy rating on Denali Therapeutics (DNLI – Research Report) today. The company’s shares opened ...